Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
May 10, 2016 $15.10 $15.10 $15.10 $15.10 251 882
May 09, 2016 $15.10 $15.10 $15.10 $15.10 223 969
May 06, 2016 $14.70 $14.70 $14.70 $14.70 242 425
May 05, 2016 $14.96 $14.96 $14.96 $14.96 245 934
May 04, 2016 $15.73 $15.73 $15.73 $15.73 226 217
May 03, 2016 $16.15 $16.15 $16.15 $16.15 264 406
May 02, 2016 $17.00 $17.00 $17.00 $17.00 211 172
Apr 29, 2016 $16.88 $16.88 $16.88 $16.88 410 246
Apr 28, 2016 $16.69 $16.69 $16.69 $16.69 1 013 928
Apr 27, 2016 $17.50 $17.50 $17.50 $17.50 446 699
Apr 26, 2016 $17.62 $17.62 $17.62 $17.62 271 208
Apr 25, 2016 $18.38 $18.38 $18.38 $18.38 131 992
Apr 22, 2016 $18.83 $18.83 $18.83 $18.83 288 733
Apr 21, 2016 $18.08 $18.08 $18.08 $18.08 180 153
Apr 20, 2016 $17.28 $17.28 $17.28 $17.28 275 134
Apr 19, 2016 $17.70 $17.70 $17.70 $17.70 291 712
Apr 18, 2016 $18.59 $18.59 $18.59 $18.59 332 656
Apr 15, 2016 $18.06 $18.06 $18.06 $18.06 241 388
Apr 14, 2016 $18.23 $18.23 $18.23 $18.23 204 561
Apr 13, 2016 $17.81 $17.81 $17.81 $17.81 299 254
Apr 12, 2016 $16.60 $16.60 $16.60 $16.60 160 420
Apr 11, 2016 $16.73 $16.73 $16.73 $16.73 156 636
Apr 08, 2016 $17.10 $17.10 $17.10 $17.10 256 460
Apr 07, 2016 $17.43 $17.43 $17.43 $17.43 273 963
Apr 05, 2016 $16.36 $16.36 $16.36 $16.36 241 593
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT